Forescribe Pricing Overview

Yes. According to G2 data, Forescribe offers a free plan with limited features. Users can upgrade to paid plans for additional capabilities. Visit the seller's official pricing page to compare plan options and features.

According to G2 data, Forescribe pricing in 2026 starts at $239.00 and can reach $359.00 depending on the selected plan. Pricing may vary based on billing terms or usage, so users should review the Forescribe's official pricing page for the most current details.

Forescribe's pricing is best suited for mid-market organizations (51–1,000 employees) based on the concentration of G2 reviewers from that segment across industries including IT services, healthcare, banking, logistics, and education. The Essential tier fits smaller mid-market teams managing up to 50 SaaS subscriptions with lean IT staff, while the Pro tier targets growing organizations with multiple teams, heavier SaaS sprawl, and forecasting needs. G2 enterprise reviewers in healthcare, telecom, and government also report strong fit, particularly for governance, compliance, and multi-region visibility. Small businesses benefit from the free Spark tier, which G2 users confirm delivers immediate visibility without requiring a budget commitment.

Forescribe's free Spark tier offers a surprisingly capable entry point — SaaS spend visibility, AI-driven optimization, app utilization analytics, security and compliance monitoring, and deep integrations are all included at no cost. The primary limitations are scale and support. Forescribe's paid plans introduce hard subscription caps (50 apps and 100 employees on Essential at $239.00/year; 100 apps and 500 employees on Pro at $359.00/year), multiple admin seats, financial integrations, predictive analytics, smart renewal dashboards, and live chat or phone support. G2 reviewers in mid-market segments frequently cite renewal management and license recovery as key drivers for upgrading beyond the free tier.

G2 reviewers consistently rate Forescribe at 4.5–5.0 across mid-market and enterprise segments, signaling strong cost-to-value alignment. Reviewers in IT, healthcare, banking, and logistics highlight concrete returns: eliminated redundant licenses, avoided surprise renewals, and reduced shadow IT — outcomes that directly offset subscription costs. The free Spark tier delivers immediate value with no financial commitment, while Forescribe's paid plans starting at $239.00/year are frequently described as delivering outsized impact relative to cost. Minor cons center on reporting flexibility, not pricing. No reviewer flags Forescribe's pricing as prohibitive or mentions switching to a cheaper alternative, reinforcing its reputation as strong value across company sizes.